CEPHEID (CPHD)
CEPHEID News
Canaccord Genuity Reiterates a 'Buy' on Cepheid (CPHD); Rolling Out Another Assay
Street Insider about 4 days agoFinancial Breakfast: Morning News Summary for May 24, 2012
Benzinga about 4 days agoA Peek Into The Market Before The Trading Starts
Benzinga about 4 days agoCepheid (CPHD) Receives FDA Approval for GeneXpert Infinity-80 System
Street Insider about 4 days agoCepheid Receives FDA Clearance for GeneXpert Infinity-80 System for Initial Use with Xpert Flu Assay
Benzinga about 4 days agoMyriad Reiterated Neutral
about 10 days ago[video] Analyst Moves: AMZN, CPHD
about 13 days agoCepheid shares rise on UBS analyst's upgrade
AP about 13 days agoShares of Cepheid Inc. traded higher Tuesday after a UBS analyst upgraded the diagnostics company's stock,THE SPARK: Analyst Daniel Arias upgraded the stock to "Buy" from "Neutral." ...
Analyst Moves: AMZN, CPHD
about 13 days agoUPDATE: UBS Investment Research Upgrades Cepheid to Buy; Opportunistic Inflection
Benzinga about 13 days agoUBS Upgrades Cepheid (CPHD) to Buy
Street Insider about 13 days agoBenzinga's Top Downgrades With Color for May 14, 2012
Benzinga about 14 days agoUPDATE: GARP Research & Securities Downgrades Cepheid to Neutral; Valuation Full
Benzinga about 14 days agoGARP Research Downgrades Cepheid (CPHD) to Neutral; Walking A Thin Line
Street Insider about 14 days agoGARP Research Cuts Cepheid (CPHD) to Neutral
Street Insider about 14 days agoYou may also be interested in these CPHD related companies
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| CPHD | 38.47 | +0.38 | +1.00% | 2.519B |
| DLB | 43.96 | -0.04 | -0.09% | 4.777B |
| DLA | 14.17 | -0.03 | -0.21% | 119.74M |
| DL | 3.40 | -0.07 | -2.02% | 120.60M |
| DKA | 21.58 | -0.07 | -0.32% | |
| DK | 16.91 | +0.47 | +2.86% | 983.49M |
| DCOM | 13.34 | +0.04 | +0.30% | 469.17M |
| DCM | 15.83 | -0.05 | -0.31% | 65.64B |
| DCIX | 7.07 | -0.02 | -0.28% | 163.18M |
| DCI | 36.12 | -0.15 | -0.41% | 5.379B |
